Clinical Trials Logo

Acute Renal Failure clinical trials

View clinical trials related to Acute Renal Failure.

Filter by:

NCT ID: NCT03627884 Completed - Clinical trials for End Stage Renal Disease

Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation

Start date: October 1, 2016
Phase: Phase 4
Study type: Interventional

Prospective, randomized, comparative clinical and open-label trial comparing sodium bicarbonate catheter lock solution (SBCLS) to normal saline catheter lock solution (NSCLS) use in HD patients with central venous catheters (CVC).

NCT ID: NCT03536195 Completed - Hemorrhage Clinical Trials

Impact of Renal Replacement Therapy on Coagulation Profile of Patients With Acute Renal Failure

HEMOSTIR
Start date: June 20, 2018
Phase:
Study type: Observational

Renal failure and high plasmatic level of urea have been associated with an increased risk of hemorrhage in surgical patients. There is only sparse data on the impact of renal replacement therapy on homeostatic parameters. The aim of this study is to describe potential changes in homeostatic parameters before and after renal replacement therapy.

NCT ID: NCT03353389 Completed - Acute Kidney Injury Clinical Trials

Review of Trend in Incidence and Characteristics of Hospital-acquired Acute Kidney Injury in Hospital Selayang

HA-AKI-HS
Start date: November 1, 2017
Phase:
Study type: Observational

This retrospective cohort study aims to investigate the incidence, risk factors and outcomes of Hospital-acquired Acute Kidney Injury in Hospital Selayang, a tertiary hospital at Malaysia, over 15 years.

NCT ID: NCT03314363 Completed - Acute Renal Failure Clinical Trials

Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry

MECCIAS
Start date: April 26, 2017
Phase: N/A
Study type: Interventional

The aim of the present study is to assess the metabolic impact of Continuous Renal Replacement Therapy and overview the obstacles and important factors compromising the use of Indirect Calorimetry in CRRT and suggest a model to overcome these issues.

NCT ID: NCT03231748 Completed - Acute Renal Failure Clinical Trials

Clearance of Inflammatory Cytokines During Renal Replacement Therapy Using the EMIC®2 Filter

ClicAKI
Start date: July 1, 2017
Phase:
Study type: Observational

This study will be conducted in patients with sepsis and acute kidney injury needing renal replacement therapy. The aim is to investigate whether continuous renal replacement therapy with the EMIC®2 filter leads to removal of pro-inflammatory middle molecular weight cytokines from the blood.

NCT ID: NCT03229941 Completed - Clinical trials for Myocardial Infarction

Transfusion Trigger After Operations in High Cardiac Risk Patients

TOP
Start date: February 5, 2018
Phase: N/A
Study type: Interventional

The goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb < 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative outcomes compared to a restrictive transfusion strategy (transfusion trigger at Hb < 7 gm/dl).

NCT ID: NCT03004950 Completed - Clinical trials for Chronic Kidney Disease

Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)

Start date: October 1, 2016
Phase:
Study type: Observational

This study is an observational non-interventional study which will examine a) the accuracy of biomarkers in predicting renal and cardiovascular outcomes after contrast-induced acute kidney injury. This study will obtain de-identified human plasma & urine samples and corresponding de-identified research study data on subjects who are enrolled into the Prevention of Serious Adverse Events Following Angiography (PRESERVE) study and Biomarker Collection and Analysis in the PRESERVE Trial (VA CSP #578). Biomarker analyses will be performed on the de-identified samples and merged with de-identified research study data.

NCT ID: NCT02889575 Completed - Acute Renal Failure Clinical Trials

Predictive Value of PIIINP and Urinary NGAL in Renal Function Recovery

PIIINP-NGAL
Start date: April 2012
Phase: N/A
Study type: Observational

Acute Renal Failure (ARF) is defined by a severe, and usually reversible, glomerular filtration rate decreasing. Acute Tubular Necrosis (ATN) remain the major cause of ARF involving distress and destruction of tubular cells. This specific typology of ARF may evolve toward Chronic Renal Failure (CRF) concretizing a major public health issue. Predict the progression of ARF towards CRF appears essential. The investigators believe that the PIIINP and urinary NGAL biomarkers may constitute robust biomarkers of progression risk towards CRF.

NCT ID: NCT02858531 Completed - Elderly Clinical Trials

Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics

PREDAFLU
Start date: September 1, 2016
Phase:
Study type: Observational

Epidemics and infectious diseases in general, punctuate much of the activity of an emergency service. The impact of winter infections is particularly important to vulnerable populations such as infant during bronchiolitis epidemics and the elderly during seasonal influenza. Each year, these epidemic phenomena lead to disorganization of emergency services and healthcare teams by lack of anticipation and organizational measures in particular to manage the approval of emergency services for the most vulnerable populations requiring hospitalization. For 2 years, the pediatric emergency department of St Etienne University Hospital has a decision support tool for the periods of winter epidemics. Through a retrospective analysis of Passages of Emergency summary, this tool provides an estimate of infants with bronchiolitis flow day to day, and the availability in real time of an abnormally high flow of patients to pediatric emergencies. These data can help to affirm that the epidemic begins in this hospital.

NCT ID: NCT02672930 Completed - Clinical trials for Chronic Renal Failure

How Much Reliable iv Calcium for the Treatment of Hyperkalemia?

Start date: July 2015
Phase:
Study type: Observational [Patient Registry]

Hyperkalemia is a common problem in the emergency services and one of the life threatening metabolic emergencies. Calcium, insulin, beta adrenoceptor agonists, bicarbonate, diuretics, sodium polystyrene sulfonate and lastly dialysis are advised in treatment. Especially, avoiding evolution of serious arrythmias and iv calcium using in the treatment of occured electrocardiogram (ECG) abnormalities, there is not sufficient level of survey in the literature. So the aim of this study was to evaluate administration of iv calcium efficiency on vital signs and ECG.